Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2025-12-25 @ 2:52 AM
NCT ID:
NCT01591733
Eligibility Criteria:
Inclusion Criteria:
* Cytologic or histologic proof pancreatic ductal carcinoma
* Borderline resectable
* Life expectancy of at least 3 months
* ECOG Performance Status ≤ 1
* Adequate organ and bone marrow function
* No treatment of other invasive cancers within the last 5 years with greater than 5% risk of recurrence at the time of eligibility screening. Carcinoma in-situ and basal cell carcinoma/squamous cell carcinoma of the skin are allowed
* \> 4 weeks since major surgery, excluding laparoscopy
Exclusion Criteria:
* Evidence of metastatic disease
* Pregnant or breastfeeding
* Other serious uncontrolled medical conditions
* Prior chemotherapy, targeted/biologic therapy or radiation for treatment of the pancreatic tumor
* Prior systemic fluoropyrimidine therapy
* History of uncontrolled seizures, central nervous system disorders or psychiatric disability
* Individuals on cimetidine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01591733
Study Brief:
Protocol Section:
NCT01591733